North Carolina university supported as centre of nanotechnology by National Cancer Institute

Published: 10-Oct-2005

The US National Cancer Institute, part of the US National Institutes of Health, has named the University of North Carolina-Chapel Hill one of seven centres of cancer nanotechnology research.


The US National Cancer Institute, part of the US National Institutes of Health, has named the University of North Carolina-Chapel Hill one of seven centres of cancer nanotechnology research.

These centres form part of a US$144m, five-year initiative to develop and apply nanotechnology for the detection, diagnosis and treatment of cancer.

The Carolina Center of Cancer Nanotechnology Excellence (CCNE) will be headed by principal investigator Professor Rudolph Juliano and co-principal investigator Professor Joseph DeSimone.

The centre has already developed, along with Liquidia Technologies, PRINT particle technology, which provides control over shape, size and composition of material when manufacturing nanoparticles, resulting in drug delivery systems previously unattainable. The technology includes the development of microfluidic chips from a novel fluoropolymer technology.

You may also like